SE7701216L - B-laktanforeningar - Google Patents

B-laktanforeningar

Info

Publication number
SE7701216L
SE7701216L SE7701216A SE7701216A SE7701216L SE 7701216 L SE7701216 L SE 7701216L SE 7701216 A SE7701216 A SE 7701216A SE 7701216 A SE7701216 A SE 7701216A SE 7701216 L SE7701216 L SE 7701216L
Authority
SE
Sweden
Prior art keywords
hydrogen
useful
lower alkyl
group
conjugating group
Prior art date
Application number
SE7701216A
Other languages
English (en)
Swedish (sv)
Inventor
E Hunt
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of SE7701216L publication Critical patent/SE7701216L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE7701216A 1976-02-04 1977-02-03 B-laktanforeningar SE7701216L (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB4320/76A GB1529913A (en) 1976-02-04 1976-02-04 Beta-lactam compounds
GB859776 1976-03-04
GB1534676 1976-04-14
GB2422776 1976-06-11

Publications (1)

Publication Number Publication Date
SE7701216L true SE7701216L (sv) 1977-08-05

Family

ID=27447370

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7701216A SE7701216L (sv) 1976-02-04 1977-02-03 B-laktanforeningar

Country Status (15)

Country Link
US (1) US4206120A (es)
JP (1) JPS5297994A (es)
AT (1) AT352875B (es)
AU (1) AU506250B2 (es)
BE (1) BE850942A (es)
CH (1) CH636357A5 (es)
DE (1) DE2704104A1 (es)
DK (1) DK46677A (es)
ES (1) ES455625A1 (es)
FR (1) FR2340321A1 (es)
GB (1) GB1529913A (es)
IE (1) IE44460B1 (es)
IL (1) IL51339A (es)
NL (1) NL7701191A (es)
SE (1) SE7701216L (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136132A (en) * 1975-02-17 1982-11-23 Teruji Tsuji Cyclization to form cephem ring and intermediates therefor
GB1593275A (en) * 1976-10-22 1981-07-15 Glaxo Lab Ltd Clavam derivatives
EP0000615B1 (en) * 1977-07-23 1981-04-29 Beecham Group Plc Beta-lactam compounds, preparation and use in pharmaceutical compositions and as chemical intermediates
DE2861335D1 (en) * 1977-11-29 1982-01-21 Beecham Group Plc Clavulanic acid derivatives, a process for their preparation and compositions containing them
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
EP0024372A1 (en) * 1979-08-03 1981-03-04 Beecham Group Plc Derivatives of clavulanic acid, their preparation and pharmaceutical compositions containing them
EP0025287A1 (en) * 1979-08-21 1981-03-18 Beecham Group Plc Clavulanic acid derivatives, their preparation, pharmaceutical compositions containing them and their preparation
US4562182A (en) * 1980-12-23 1985-12-31 Beecham Group P.L.C. Compounds containing beta-lactams
EP0057664A3 (de) * 1981-01-30 1982-11-17 Ciba-Geigy Ag Clavam-Derivate
DE3725375A1 (de) * 1987-07-31 1989-02-09 Bayer Ag Stabile oxapenem-3-carbonsaeuren
GB9421816D0 (en) * 1994-10-29 1994-12-14 Smithkline Beecham Plc Novel compounds
FR2739851B1 (fr) 1995-10-13 1997-11-21 Oreal Nouveaux derives alkyl-3-oxo-alcanoates et leur procede de preparation
US5767316A (en) 1995-11-17 1998-06-16 Ajinomoto Co., Inc. Process for producing 3-amino-2-oxo-1-halogenopropane derivatives
EP2477993B1 (de) 2009-09-15 2015-06-24 Nabriva Therapeutics AG Substituierte clavulansäure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1542405A (en) * 1975-04-15 1979-03-21 Beecham Group Ltd Clavulanic acid derivatives

Also Published As

Publication number Publication date
DE2704104A1 (de) 1977-08-11
FR2340321B1 (es) 1980-03-07
IE44460B1 (en) 1981-12-02
IL51339A0 (en) 1977-03-31
AU506250B2 (en) 1979-12-20
NL7701191A (nl) 1977-08-08
US4206120A (en) 1980-06-03
ATA65177A (de) 1979-03-15
AU2193177A (en) 1978-08-10
DK46677A (da) 1977-05-16
AT352875B (de) 1979-10-10
IE44460L (en) 1977-08-04
BE850942A (fr) 1977-08-01
JPS5297994A (en) 1977-08-17
IL51339A (en) 1980-03-31
CH636357A5 (de) 1983-05-31
GB1529913A (en) 1978-10-25
FR2340321A1 (fr) 1977-09-02
ES455625A1 (es) 1978-05-16

Similar Documents

Publication Publication Date Title
SE7701216L (sv) B-laktanforeningar
SE8104132L (sv) Mjuka steroider med antiiflammatorisk verkan
SE7611047L (sv) Forfarande for framstellning av antibakteriella emnen
AU532120B2 (en) Chromophoric cephalosporins
SE7710873L (sv) Nya 1h-pyrazolo(3,4-b)pyridiner
SE8003821L (sv) Nya 3-aminovinylcefalosporiner och forfarande for framstellning derav
FR2373546A1 (fr) Derives thio-oxime de cephalosporines et de penicillines, utiles comme inhibiteurs de b-lactamases
SE7713704L (sv) Propionsyraderivat och sett for framstellning av desamma
SE7702668L (sv) Nya stilbenforeningar och forfarande for deras framstellning
ATE9790T1 (de) 1,4-naphthochinonderivate und deren verwendung.
AU536912B2 (en) Benzothiazole derivatives
FR2355848A1 (fr) 7-(a-(2,3-dihydro-2-oxobenzimidazol-1-yl-carbonylamino) arylacetamido) cephalosporines
SE7706655L (sv) Nya bensylcyanoacetaler och sett att framstella dessa
IL59053A (en) N-azolyl-acetanilides,their manufacture and their use as herbicides
ES475780A1 (es) Un proceso para la produccion de nueva penicilina y deriva- dos cefalosporinicos
FI810618L (fi) Nya kefalosporiner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
MC1277A1 (fr) Esters et ethers de cephalosporine
ES457370A1 (es) Procedimiento de preparacion de nuevos derivados del nafta- leno.
ATE28192T1 (de) 4-alkylimidazol-derivate, ihre herstellung und verwendung.
GB1440160A (en) 2,4-dioxo-1-pyrimidinyl penicillin and cephalosporin deri vatives
FR2361364A1 (fr) Nouveaux derives d'azetidine
SE7503274L (sv) Cefalosporin
FI824155L (fi) Foerfarande foer framstaellning av 3,7a-diazacyklohepta/j,k/fluoren
GB2004273A (en) beta -Lactam compounds, preparation and use
ATE83775T1 (de) N-phenyltetrahydrophthalimidverbindungen.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7701216-9

Format of ref document f/p: F